相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology
Masashi Mizuno et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2018)
Resveratrol inhibits LPS-induced mice mastitis through attenuating the MAPK and NF-κB signaling pathway
Xu Zhang et al.
MICROBIAL PATHOGENESIS (2017)
SUCCESSFUL TREATMENT OF C1Q NEPHROPATHY WITH CD19 TARGETED RITUXIMAB THERAPY
Raja Ramachandran et al.
NEPHROLOGY (2017)
Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice
Y. Zhang et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2017)
Resveratrol attenuates skeletal muscle atrophy induced by chronic kidney disease via MuRF1 signaling pathway
Li-Jing Sun et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Focal Segmental Glomerulosclerosis
Avi Z. Rosenberg et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
FSGS: from pathogenesis to the histological lesion
Andrea Angioi et al.
JOURNAL OF NEPHROLOGY (2016)
Polydatin attenuates AGEs-induced upregulation of fibronectin and ICAM-1 in rat glomerular mesangial cells and db/db diabetic mice kidneys by inhibiting the activation of the SphK1-S1P signaling pathway
Cheng Chen et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2016)
Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease
Sara Heeboll et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2016)
C5a/C5aR pathway is essential for up-regulating SphK1 expression through p38-MAPK activation in acute liver failure
Yan-Chang Lei et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Acute Resveratrol Consumption Improves Neurovascular Coupling Capacity in Adults with Type 2 Diabetes Mellitus
Rachel H. X. Wong et al.
NUTRIENTS (2016)
FSGS: Diagnosis and Diagnostic Work-Up
Ben Sprangers et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Treatment Strategies of Adult Primary Focal Segmental Glomerulosclerosis: A Systematic Review Focusing on the Last Two Decades
Arno Beer et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Circulating Permeability Factors in Primary Focal Segmental Glomerulosclerosis: A Review of Proposed Candidates
Eva Koenigshausen et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Pathogenesis of Focal Segmental Glomerulosclerosis
Beom Jin Lim et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2016)
Molecules Great and Small: The Complement System
Douglas R. Mathern et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Astaxanthin Attenuates Adriamycin-Induced Focal Segmental Glomerulosclerosis
Guoyong Liu et al.
PHARMACOLOGY (2015)
Targeting the Sphingosine Kinase/Sphingosine 1-Phosphate Pathway to Treat Chronic Inflammatory Kidney Diseases
Stephanie Schwalm et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2014)
Resveratrol as a therapeutic agent for renal fibrosis induced by unilateral ureteral obstruction
Jin Liang et al.
RENAL FAILURE (2014)
Activation of the Interleukin-4/Signal Transducer and Activator of Transcription 6 Signaling Pathway and Homeodomain-Interacting Protein Kinase 2 Production by Tonsillar Mononuclear Cells in IgA Nephropathy
Liyu He et al.
AMERICAN JOURNAL OF NEPHROLOGY (2013)
Resveratrol: Why Is It a Promising Therapy for Chronic Kidney Disease Patients?
Juliana F. Saldanha et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
Pathophysiology and treatment of focal segmental glomerulosclerosis: the role of animal models
Sylvana M. L. de Mik et al.
BMC NEPHROLOGY (2013)
Loss of GM3 synthase gene, but not sphingosine kinase 1, is protective against murine nephronophthisis-related polycystic kidney disease
Thomas A. Natoli et al.
HUMAN MOLECULAR GENETICS (2012)
Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: A triple-blind, 6-month follow-up, placebo-controlled, randomized trial
Joao Tome-Carneiro et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2012)
Sphingosine Kinase-1 Pathway Mediates High Glucose-Induced Fibronectin Expression in Glomerular Mesangial Cells
Tian Lan et al.
MOLECULAR ENDOCRINOLOGY (2011)
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
Changli Wei et al.
NATURE MEDICINE (2011)
Rapamycin Attenuates the Severity of Murine Adriamycin Nephropathy
Sing Leung Lui et al.
AMERICAN JOURNAL OF NEPHROLOGY (2009)
Transforming growth factor-β2 upregulates sphingosine kinase-1 activity, which in turn attenuates the fibrotic response to TGF-β2 by impeding CTGF expression
Shuyu Ren et al.
KIDNEY INTERNATIONAL (2009)
Sphingosine kinase signalling in immune cells: Potential as novel therapeutic targets
Ahrio J. Melendez
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)
Pathology, Clinical Presentations, and Outcomes of C1q Nephropathy
Alenka Vizjak et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Glomerular proliferation during early stages of diabetic nephropathy is associated with local increase of sphingosine-1-phosphate levels
K Geoffroy et al.
FEBS LETTERS (2005)
Sphingosine 1-phosphate cross-activates the Smad signaling cascade and mimics transforming growth factor-β-induced cell responses
CY Xin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
被撤回的出版物: Antisense knockdown of sphingosine kinase 1 in human macrophages inhibits C5a receptor-dependent signal transduction, Ca2+ signals, enzyme release, cytokine production, and chemotaxis (Retracted article. See vol. 190, pg. 3005, 2013)
AJ Melendez et al.
JOURNAL OF IMMUNOLOGY (2004)
Anaphylatoxin signaling in human neutrophils - A key role for sphingosine kinase
FBM Ibrahim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
分享论文
